Drew Capurro

drew.capurro@lw.com

+1.714.755.8008

Profile

Drew Capurro is Regional Vice Chair of the Southern California Corporate Department and a partner in the Orange County office. He is a strategic advisor for his clients with a practice that focuses primarily on the representation of public and private companies, with deep experience in the life sciences, technology, homebuilder, and consumer retail industries. He also regularly represents investment banks in transactions with these companies.

Drew has a particular emphasis in public and private capital markets transactions and has represented issuers and underwriters in a broad range of matters, including:

Initial public offerings
De-SPAC transactions
Secondary and follow-on offerings
Preferred stock offerings
Registered and 144A convertible debt offerings
High yield debt offerings
Strategic investments

Experience

Drew’s recent transactional experience representing companies includes:

Mister Car Wash in its US$647 million initial public offering and subsequent US$235 million follow-on
JOANN in its US$131 million initial public offering
PROCEPT BioRobotics in its US$188 million initial public offering and subsequent US$161 million follow-on offering
Winc in its initial public offering
Guardant Health in its US$273 million initial public offering and subsequent common stock and convertible note financings
Virgin Galactic in its business combination transaction with a special purpose acquisition company and subsequent common stock and convertible debt offerings
Ouster in its business combination transaction with a special purpose acquisition company and subsequent financing transactions and merger of equals with Velodyne
Offerpad in its business combination transaction with a special purpose acquisition company and subsequent equity financings
Owlet in its business combination transaction with a special purpose acquisition company and subsequent preferred stock financing
SciPlay in its US$352 million IPO
Switch in its US$611 million IPO
Boxed in its business combination transaction with a special purpose acquisition company and subsequent liquidity management transaction
Planet Labs in its business combination transaction with a special purpose acquisition company
GCM Grosvenor in its business combination transaction with a special purpose acquisition company
Advantage Solutions in its business combination transaction with a special purpose acquisition company
Virgin Orbit in its business combination transaction with a special purpose acquisition company
MultiSensor AI, a provider of intelligent thermal imaging platforms, in its business combination with a special purpose acquisition company.
AEON Biopharma, a clinical-stage biopharmaceutical company developing a proprietary botulinum toxin for the treatment of multiple debilitating medical conditions, in its business combination with a special purpose acquisition company

Drew also regularly advises private and public companies at all stages of maturity in strategic matters involving corporate governance, state and federal securities laws, fiduciary duties, employment and compensation, and Securities Exchange Act compliance and disclosure obligations.

Drew’s recent transactional experience representing investment banks includes:

The underwriters in connection with the US$143 million IPO of Vir Biotechnology, Inc., and its US$345 million follow-on offering
The underwriters in connection with the US$90 million IPO of Spruce Biosciences, Inc.
The underwriters in connection with the US$70 million IPO of Avedro, Inc.
The underwriters in connection with the US$107.5 million IPO of Neuronetics, Inc.
The initial purchasers in connection with US$600 million convertible note offering by BioMarin
The initial purchasers in connection with US$287.5 million convertible note offering by Glaukos

Recent clients among underwriters include Goldman Sachs, J.P. Morgan, Bank of America, Piper Jaffray, and Cowen.